Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study.
- DOI
- 10.1111/dom.13575
- Published
- 2019 Apr
- Container
- Diabetes, obesity & metabolism
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/dom.13575,
title = {Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study.},
author = {Itoh H and Komuro I and Takeuchi M and Akasaka T and Daida H and Egashira Y and Fujita H and Higaki J and Hirata KI and Ishibashi S and Isshiki T and Ito S and Kashiwagi A and Kato S and Kitagawa K and Kitakaze M and Kitazono T and Kurabayashi M and Miyauchi K and Murakami T and Murohara T and Node K and Ogawa S and Saito Y and Seino Y and Shigeeda T and Shindo S and Sugawara M and Sugiyama S and Terauchi Y and Tsutsui H and Ueshima K and Utsunomiya K and Yamagishi M and Yamazaki T and Yo S and Yokote K and Yoshida K and Yoshimura M and Yoshimura N and Nakao K and Nagai R and EMPATHY Investigators},
year = {2019},
journal = {Diabetes, obesity \& metabolism},
doi = {10.1111/dom.13575},
url = {https://doi.org/10.1111/dom.13575}
}RIS
TY - JOUR TI - Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study. AU - Itoh H AU - Komuro I AU - Takeuchi M AU - Akasaka T AU - Daida H AU - Egashira Y AU - Fujita H AU - Higaki J AU - Hirata KI AU - Ishibashi S AU - Isshiki T AU - Ito S AU - Kashiwagi A AU - Kato S AU - Kitagawa K AU - Kitakaze M AU - Kitazono T AU - Kurabayashi M AU - Miyauchi K AU - Murakami T AU - Murohara T AU - Node K AU - Ogawa S AU - Saito Y AU - Seino Y AU - Shigeeda T AU - Shindo S AU - Sugawara M AU - Sugiyama S AU - Terauchi Y AU - Tsutsui H AU - Ueshima K AU - Utsunomiya K AU - Yamagishi M AU - Yamazaki T AU - Yo S AU - Yokote K AU - Yoshida K AU - Yoshimura M AU - Yoshimura N AU - Nakao K AU - Nagai R AU - EMPATHY Investigators PY - 2019 JO - Diabetes, obesity & metabolism DO - 10.1111/dom.13575 UR - https://doi.org/10.1111/dom.13575 ER -
APA
H, I., I, K., M, T., T, A., H, D., Y, E., H, F., J, H., KI, H., S, I., T, I., S, I., A, K., S, K., K, K., M, K., T, K., M, K., K, M., T, M., T, M., K, N., S, O., Y, S., Y, S., T, S., S, S., M, S., S, S., Y, T., H, T., K, U., K, U., M, Y., T, Y., S, Y., K, Y., K, Y., M, Y., N, Y., K, N., R, N., & Investigators, E. (2019). Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.13575
Source records
- pubmed · retrieved 2026-09-26T10:48:56.108Z